✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Sakar Healthcare Ltd.

SAKAR

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹900 Cr.
P/E
46.17

Sakar Healthcare Ltd.

  • Sakar Healthcare
  • Gufic Biosciences
  • Caplin Point Lab

FAQs on Sakar Healthcare Ltd. Shareprice

Sakar Healthcare has given better returns compared to its competitors.
Sakar Healthcare has grown at ~31.87% over the last 7yrs while peers have grown at a median rate of 23.99%

Yes, Sakar Healthcare is expensive.
Latest PE of Sakar Healthcare is 45.15, while 3 year average PE is 40.15.
Also latest EV/EBITDA of Sakar Healthcare is 18.48 while 3yr average is 17.22.

View FAQ's On Business

Growth Table

  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab

Balance Sheet

  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab

Cash Flow

  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab

Quarterly Results

  • Sakar Healthcare Ltd.
  • Gufic Biosciences
  • Caplin Point Lab

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Sakar Healthcare Ltd. Financials

Balance sheet of Sakar Healthcare is strong.
But short term working capital might become an issue for this company.

The net debt of Sakar Healthcare is decreasing.
Latest net debt of Sakar Healthcare is ₹71.65 Crs as of Sep-25.
This is less than Mar-25 when it was ₹85.85 Crs.

Yes, profit is increasing.
The profit of Sakar Healthcare is ₹19.5 Crs for TTM, ₹17.5 Crs for Mar 2025 and ₹11.67 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sakar Healthcare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech